Less Ads, More Data, More Tools Register for FREE

Pin to quick picksB.p Marsh Regulatory News (BPM)

Share Price Information for B.p Marsh (BPM)

Share Price is delayed by 15 minutes
Get Live Data
701.00    0.00 (0.00%)
Bid:
692.00
Ask:
710.00
Spread: 18.00 (2.601%)
Market Cap: £247.03m
BPM Live PriceLast checked at - London Stock Exchange

Intraday B.p Marsh Share Chart

Establishment of Share Incentive Plan

29 Mar 2016 18:08

RNS Number : 4604T
B.P. Marsh & Partners PLC
29 March 2016
 

Date:

On behalf of: B.P. Marsh & Partners Plc

Immediate Release

B.P. Marsh & Partners Plc

("B.P. Marsh" or the "Company")

Establishment of a Share Incentive Plan

 

B.P. Marsh, the niche venture capital provider to early stage financial services businesses, today announces that, as part of encouraging all employees to be shareholders in the Company, it has established an HMRC sanctioned Share Incentive Plan ("SIP").

 

Therefore, a total of 97,652 ordinary shares of 10 pence each ("Ordinary Shares") in the Company, which are currently held in Treasury, have been transferred to the B.P. Marsh SIP Trust.

 

A total of 9 employees were found to be eligible and applied for the 2015-16 SIP and have each today been granted 2,408 Ordinary Shares ("15-16 Free Shares"), representing £3,600 as at the current share price. The 15-16 Free Shares which have been awarded are subject to a 1 year forfeiture period.

 

Additionally, a total of 9 eligible employees applied for the 2016-17 SIP and will each be granted a number of Ordinary Shares ("16-17 Free Shares"), representing £3,600 at the price of issue. All eligible employees have been invited to take up the opportunity to acquire up to £1,800 worth of Ordinary Shares ("Partnership Shares"). For every Partnership Share that an employee acquires, the SIP Trust will offer two Ordinary Shares ("Matching Shares") up to a total of £3,600 worth of shares. The 16-17 Free, Partnership and Matching Shares will be awarded on 27th June 2016, with the 16-17 Free and Matching Shares being subject to a 1 year forfeiture period.

 

The Directors have participated in this award and further details of which (as at today's date) are set out below:

 

Directors

Ordinary Shares held under SIP

Ordinary Share held under JSOP

Ordinary Shares held directly

Alice Foulk

2,408

127,901

Dan Topping

2,408

355,283

31,924

Jon Newman

2,408

355,283

Millie Kenyon

2,408

241,592

 

As a result of the above, the total number of Ordinary Shares in issue is 29,226,040, and the total number of voting rights in B.P. Marsh, is 29,150,060. This figure may be used by shareholders as the denominator for the calculations by which they will determine whether they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure and Transparency Rules.

Mr. Brian Marsh OBE, Chairman of the Group stated "There is no doubt that it is very desirable for staff to have a direct shareholding interest in our Company and I am delighted that this has been arranged as set out above, which is clearly in shareholders' best interests. I hope that both will benefit from increases in the underlying value of the Company over the months and years ahead.

The take-up has been very positive, with all eligible employees subscribing for their full entitlements, and I would hope that this is something that the Company can offer on an ongoing basis, engendering long term loyalty throughout the Group."

 

For further information:

B.P. Marsh & Partners Plc www.bpmarsh.co.uk

Brian Marsh OBE / Camilla Kenyon +44 (0)20 7233 3112

 

Nominated Adviser & Broker

Panmure Gordon

Fred Walsh / Charles Leigh-Pemberton / Atholl Tweedie +44 (0)20 7886 2500

 

Notes to Editors:

 

About B.P. Marsh & Partners Plc

B.P. Marsh's current portfolio contains fourteen companies. More detailed descriptions of the portfolio can be found at www.bpmarsh.co.uk.

Since formation over 25 years ago, the Company has assembled a management team with considerable experience both in the financial services sector and in managing private equity investments. Many of the directors have worked with each other in previous roles, and all have worked with each other for at least five years.

Prior to Brian Marsh's involvement in the Company, he spent many years in insurance broking and underwriting in Lloyd's as well as the London and overseas market. He has over 30 years' experience in building, buying and selling financial services businesses, particularly in the insurance sector.

Alice Foulk joined B.P. Marsh in September 2011 having started her career at a leading Life Assurance company. In 2014 she took over as Executive Assistant to the Chairman, running the Chairman's Office and established herself as a central part of the management team.

In February 2015 she was appointed as a Director of B.P. Marsh and a member of the Investment Committee. In January 2016 Alice was appointed Managing Director of B.P. Marsh.

In her position as Managing Director, Alice is responsible for the overall performance of the Company and monitoring the Company's overall progress towards achieving the objectives and goals of the Company, as set by the Board.

 

Dan Topping is the Chief Investment Officer of B.P. Marsh, having been appointed as a Director in 2011 joining the Company in February 2007, following two years at an independent London accountancy practice. Dan Topping is the Senior Executive with overall responsibility for the portfolio and investment strategy for B.P. Marsh, working alongside the Board and the Investment Directors to structure, develop, support and monitor the portfolio.

Dan graduated from the University of Durham in 2005 and is member of the Securities and Investment Institute and the Institute of Chartered Secretaries and Administrators.

Dan is a standing member of the B.P. Marsh Investment and Valuation Committees and currently serves as a Board Director across the portfolio

Camilla Kenyon was appointed as Head of Investor Relations at B.P. Marsh in February 2009, having four years' prior experience with the Company. She was appointed to the main board in 2011. Camilla is Chair of the New Business Committee evaluating new investment opportunities. She has a number of nominee directorships over two investee companies and is a standing member of the Investment Committee. She is a Member of the Investor Relations Society.

Jonathan Newman is a Chartered Management Accountant and is the Group Director of Finance and has over 17 years' experience in the financial services industry. Jonathan currently serves as a Board Director for The Broucour Group Limited and Walsingham Motor Insurance Limited, and their various subsidiary Boards, and provides senior financial advice to all companies within the Group's portfolio as well as evaluating new investment opportunities.

 'ends'

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCGMGZFNLKGVZM
Date   Source Headline
29th May 20267:00 amRNSDirector/PDMR Shareholding
27th May 20267:01 amRNSFinal Results for the Year to 31 January 2026
27th May 20267:00 amRNSDirectorate change
13th May 20267:00 amRNSTransaction in Own Shares
6th May 20267:00 amRNSNotice of Results and Investor Presentation
24th Apr 20265:50 pmRNSTransaction in Own Shares
20th Apr 20265:25 pmRNSSIP Awards, PDMR Dealings, Treasury Shares, TVR
16th Apr 20267:00 amRNSDeferred Consideration Receipt & Special Dividend
14th Apr 20267:00 amRNSTransaction in Own Shares
8th Apr 20267:00 amRNSTransaction in Own Shares
2nd Apr 20267:00 amRNSFollow-on equity purchase in Pantheon
31st Mar 20267:00 amRNSTransaction in Own Shares
30th Mar 20263:52 pmRNSDirector/PDMR Shareholding
26th Mar 20267:00 amRNSNew Share Buyback Programme
18th Mar 20267:00 amRNSNew Investment: Nine Edge Wealth Limited
18th Mar 20267:00 amRNSNew Investment: Ventura Risk Partners Holdings
17th Mar 20264:48 pmRNSSale of Interest in Amiga to Sodalis
11th Mar 20267:00 amRNSUpdate on Sodalis Capital Limited
24th Feb 20267:00 amRNSTrading Update
6th Feb 20267:00 amRNSPurchase of Own Shares and Total Voting Rights
5th Feb 202611:44 amRNSTransaction in Own Shares
21st Jan 20267:00 amRNSInterim Dividend Declaration
18th Dec 20257:00 amRNSTransaction in Own Shares & Total Voting Rights
15th Dec 20257:00 amRNSSpecial Dividend Declaration
11th Dec 20257:00 amRNSAppointment of Nominated Adviser and Joint Brokers
2nd Dec 20257:00 amRNSChange in Executive Directorship Roles
27th Nov 20256:17 pmRNSTransaction in Own Shares
27th Nov 20257:00 amRNSNew Investment: Sodalis Capital Limited
25th Nov 20254:55 pmRNSTransaction in Own Shares
24th Nov 20255:05 pmRNSTransaction in Own Shares
24th Nov 20257:00 amRNSTransaction in Own Shares
21st Nov 20257:00 amRNSTransaction in Own Shares
20th Nov 20257:00 amRNSTransaction in Own Shares
19th Nov 20257:57 amRNSTransaction in Own Shares
17th Nov 20257:00 amRNSTransaction in Own Shares
13th Nov 202512:38 pmRNS-RB.P. Marsh to present at MelloLondon
11th Nov 20255:08 pmRNSTransaction in Own Shares
7th Nov 20257:00 amRNSTransaction in Own Shares
6th Nov 20257:00 amRNSTransaction in Own Shares
5th Nov 20257:00 amRNSTransaction in Own Shares
4th Nov 20257:00 amRNSTransaction in Own Shares
30th Oct 20257:00 amRNSTransaction in Own Shares
28th Oct 20257:01 amRNSTransaction in Own Shares
28th Oct 20257:00 amRNSSale of Stewart Specialty Risk Underwriting
27th Oct 20257:00 amRNSTransaction in Own Shares
21st Oct 20257:00 amRNSHalf-year Results
7th Oct 202511:15 amRNSNotice of HY Results and Investor Presentation
30th Sep 20253:52 pmRNSNew Investment: Oneglobal Broking Holdings Limited
23rd Sep 20257:00 amRNSTrading Update
22nd Sep 20253:23 pmRNSNew Investment

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.